• FirefoxInstall the new Firefox »
  •  Dow Up 1.49% Nasdaq Up 1.15%

    More On 0J2W.L

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Biotie Therapies Corp. (0J2W.L)

    -LSE
    0.20 0.00(0.00%) Jan 2
    Add to Portfolio
    Prev Close:0.20
    Open:0.20
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:0.20 - 0.20
    52wk Range:0.20 - 56.00
    Volume:30,000
    Avg Vol (3m):N/A
    Market Cap:88.43M
    P/E (ttm):N/A
    EPS (ttm):-0.08
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in EUR.

    Headlines

    • No Headlines available for 0J2W.L at this time.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5.93
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Biotie Therapies Corp. operates as a drug development company. It focuses on the development of drugs for neurodegenerative and psychiatric disorders. Its products include Selincro (nalmefene), a dual-acting opioid system modulator that reduces al... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback